News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
281,910 Results
Type
Article (14918)
Company Profile (299)
Press Release (266687)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (79908)
Career Advice (162)
Deals (13349)
Drug Delivery (39)
Drug Development (50751)
Employer Resources (31)
FDA (5846)
Job Trends (5178)
News (145220)
Policy (10085)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (922)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21773)
ALS (124)
Alzheimer's disease (1030)
Antibody-drug conjugate (ADC) (241)
Approvals (6041)
Artificial intelligence (258)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4569)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3132)
Cardiovascular disease (238)
Career advice (147)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (566)
Cervical cancer (14)
Clinical research (43711)
Collaboration (1149)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1103)
CRISPR (86)
C-suite (552)
Cystic fibrosis (112)
Data (4320)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1379)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (48)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31678)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51715)
Executive appointments (622)
FDA (7596)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (980)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (504)
Government (1148)
Grass and pollen (3)
Guidances (166)
Healthcare (6615)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (193)
Immuno-oncology (39)
Indications (66)
Infectious disease (1207)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7356)
IRA (12)
Job creations (869)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (243)
Leadership (9)
Legal (1402)
Liver cancer (41)
Longevity (11)
Lung cancer (419)
Lymphoma (248)
Machine learning (24)
Management (7)
Manufacturing (379)
MASH (130)
Medical device (2671)
Medtech (2680)
Mergers & acquisitions (6616)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1949)
Neurotech (1)
NextGen: Class of 2026 (2035)
Non-profit (867)
Now hiring (30)
Obesity (329)
Opinion (125)
Ovarian cancer (132)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (301)
Patient recruitment (327)
Peanut (43)
People (26675)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15486)
Phase 2 (20306)
Phase 3 (12839)
Pipeline (3242)
Policy (90)
Postmarket research (853)
Preclinical (6539)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (647)
Real estate (1449)
Recruiting (12)
Regulatory (9907)
Reports (19)
Research institute (972)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2007)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (338)
Venture capital (69)
Weight loss (173)
Women's health (25)
Worklife (2)
Date
Last 7 days (344)
Last 30 days (1157)
Last 365 days (17812)
2026 (1653)
2025 (18114)
2024 (20570)
2023 (22455)
2022 (26866)
2021 (27823)
2020 (23385)
2019 (16247)
2018 (11756)
2017 (13769)
2016 (11851)
2015 (14360)
2014 (10397)
2013 (7491)
2012 (7548)
2011 (7618)
2010 (7447)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (5)
Asia (18263)
Australia (3110)
California (7078)
Canada (1837)
China (772)
Colorado (246)
Connecticut (252)
Delaware (235)
Europe (39219)
Florida (902)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (395)
India (35)
Indiana (162)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (736)
Massachusetts (5578)
Michigan (110)
Minnesota (249)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1670)
New Mexico (13)
New York (1762)
North Carolina (826)
North Dakota (6)
Northern California (3475)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1277)
Puerto Rico (9)
Rhode Island (25)
South America (215)
South Carolina (9)
Southern California (2808)
Tennessee (40)
Texas (909)
United States (23361)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
281,910 Results for "mati therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Mati Therapeutics Announces Promotion of Chris Muller to Chief Operating Officer
Mati Therapeutics Inc. announced that it has promoted Chris Muller to the position of Chief Operating Officer.
September 26, 2023
·
3 min read
Lone Star Bio
Mati Therapeutics Announces Completion of Manufacturing Facility Dedicated to Global Production of All Punctal Plug Delivery System (PPDS) Products
Mati Therapeutics Inc. announced that it has completed and now occupies a facility dedicated to manufacturing all products formulated in Mati’s proprietary Evolute® sustained ocular drug delivery platform.
September 12, 2023
·
2 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Lone Star Bio
Mati Therapeutics Announces Purchase of Rights From Novelion Therapeutics Inc.
Mati Therapeutics Inc. (“Mati”) announced that it has purchased all rights related to Mati’s Evolute Punctal Plug Delivery System (PPDS) from Novelion Therapeutics Inc. (“Novelion”). This purchase is part of Novelion’s voluntary liquidation process
February 1, 2021
·
2 min read
Policy
Ocular Therapeutix™ Announces Success in Patent Appeal Brought by Mati Therapeutics, Inc.
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., invalidated a patent held by Mati Therapeutics, Inc. (Mati) relating to a drug delivery system containing dexamethasone.
November 9, 2021
·
7 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
Press Releases
Matica Bio Secures Commercial Manufacturing Deal with U.S. Biotech Company
September 16, 2025
·
2 min read
Press Releases
Matica Biotechnology Emerges as the Go-To CDMO for Cell & Gene Therapy in 2025
October 7, 2025
·
2 min read
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
Press Releases
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
January 22, 2026
·
1 min read
1 of 28,191
Next
